Research Progress on Epigenetics of Diabetic Cardiomyopathy in Type 2 Diabetes
Diabetic cardiomyopathy (DCM) is characterized by diastolic relaxation abnormalities in its initial stages and by clinical heart failure (HF) without dyslipidemia, hypertension, and coronary artery disease in its last stages. DCM contributes to the high mortality and morbidity rates observed in diab...
Main Authors: | Jianxin Deng, Yunxiu Liao, Jianpin Liu, Wenjuan Liu, Dewen Yan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-12-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcell.2021.777258/full |
Similar Items
-
Epigenetics of methylation modifications in diabetic cardiomyopathy
by: Jing Hao, et al.
Published: (2023-03-01) -
Epigenetics in diabetic cardiomyopathy
by: Xiaozhu Ma, et al.
Published: (2024-04-01) -
Targeting epigenetics in diabetic cardiomyopathy: Therapeutic potential of flavonoids
by: Yutong Zhou, et al.
Published: (2023-01-01) -
Epigenetic role of micrornas in diabetic cardiomyopathy
by: Satish K Raut, et al.
Published: (2016-01-01) -
Exploring the Complex Relationship between Diabetes and Cardiovascular Complications: Understanding Diabetic Cardiomyopathy and Promising Therapies
by: Nilanjan Ghosh, et al.
Published: (2023-04-01)